Systematic review reveals genetic diversity of monogenic Parkinson's Disease in African populations, suggesting need for tailored genetic studies.
Monogenic PD in Africa shows allelic and locus heterogeneity with a very strong contribution of the LRRK2 p.(Gly2019Ser) founder variant in NA. Notably, in more than 98% of SSA PD patients no molecular cause was found. Next-generation sequencing-based technology could uncover novel causative variants that may be specific to these populations.
No takes yet. Share an insight, caveat, or question.
Banjaw et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: